Stocks
Sanofi (SNY) R&D US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, € | 5 692 000 000 | 6 706 000 000 | 6 706 000 000 | 6 725 000 000 | 6 728 000 000 | 8 690 000 000 | |||
| Changes by years, y/y, % | 0% | +18% | 0% | +0% | +0% | +2.7% | |||
Sanofi. R&D, €
Sanofi. R&D, changes, %
Sanofi. R&D, sum by quarters, €
Sanofi (SNY) R&D US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D, € | 3 535 000 000 | 3 535 000 000 | 1 719 000 000 | 1 719 000 000 | 1 717 000 000 | 8 690 000 000 | ||
| Changes by years, y/y, % | +94% | +94% | +10% | +10% | +5% | |||
| Changes by quarters, q/q, % | +113% | 0% | -51% | 0% | 0% | |||
